Venture Capital
Psychedelics Precision Psychiatry Company Nabs $60M In Series B Round For Advanced Clinical Trials
Alto Neuroscience Inc. received an additional $25 million in equity investment by Alpha Wave Ventures, bringing total Series B raised funding to …
